GLP-1 medications work by slowing digestion and reducing appetite, which means they can meaningfully change how much and how often you eat
Effect of the dual glucosedependent insulinotropic peptide/gulcagonlike peptide 1 receptor agonist tirzepatide on lipid profile and waist circumference: a systematic review and metaanalysis
Sleep apnea affects roughly 30 million Americans, and excess weight is a major driver of airway obstruction during sleep
Treatment should complement rather than replace lifestyle modifications, with multidisciplinary support including dietetic input, psychological support, and regular medical monitoring essential for optimal outcomes
Virtual Consultation Tool Our Process Scheduling There is no consultation needed prior to a B12 shot
GLP-1 peptides like cagrilintide and semaglutide are extremely potent at small doses, so some researchers use as little as 0.5-1 mL for these compounds